Cargando…
Progesterone receptors – animal models and cell signalling in breast cancer: Implications for breast cancer of inclusion of progestins in hormone replacement therapies
Progestins are included in menopausal hormone replacement therapy to counteract the increased risk for endometrial cancer associated with estrogen replacement therapy. Studies of hormone replacement therapy and breast cancer risk and of changes in mammographic density according to different regimens...
Autor principal: | Schairer, Catherine |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2002
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC137941/ https://www.ncbi.nlm.nih.gov/pubmed/12473171 |
Ejemplares similares
-
Progesterone receptors - animal models and cell signalling in breast cancer: Diverse activation pathways for the progesterone receptor: possible implications for breast biology and cancer
por: Lanari, Claudia, et al.
Publicado: (2002) -
Progesterone receptor membrane component 1 is phosphorylated upon progestin treatment in breast cancer cells
por: Willibald, Marina, et al.
Publicado: (2017) -
Progesterone receptors - animal models and cell signaling in breast cancer: Role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer
por: Gao, Xiuhua, et al.
Publicado: (2002) -
Progesterone vs. synthetic progestins and the risk of breast cancer: a systematic review and meta-analysis
por: Asi, Noor, et al.
Publicado: (2016) -
An overview of menopausal oestrogen–progestin hormone therapy and breast cancer risk
por: Lee, S A, et al.
Publicado: (2005)